Douglas Yale Longshore Memorial Fund for Substance
Contributions are welcome to the
Credit card donations are welcome online through the UCLA Foundation.
Checks made payable to "The UCLA Foundation" can be sent to:
UCLA ISAP - Longshore Memorial Fund
The Douglas Yale Longshore Memorial Fund for Substance Abuse Research was established in 2006 by UCLA Integrated Substance Abuse Programs (ISAP) after the untimely death of Dr. Longshore from metastatic melanoma at age 56.
Dr. Longshore was an associate director and principal investigator for UCLA ISAP and adjunct senior behavioral scientist at RAND. He began his career in substance abuse research at UCLA in 1989.
“Doug was a highly valued and esteemed colleague among his peers at UCLA and RAND, and nationally among addiction and criminology researchers,” stated M. Douglas Anglin, Ph.D., who at the time of Dr. Longshore’s death was also an associate director of ISAP. “He is remembered by his colleagues particularly for his keen intelligence, wry sense of humor, quiet and plainspoken manner, sense of fairness and integrity, kindness and consideration of others, and wide-ranging interests in art, literature, music, and film.”
Dr. Longshore’s research interests included interventions for drug-using criminal offenders; motivation for drug abuse treatment and recovery; racial/ethnic and cultural factors in drug abuse treatment utilization and recovery; and HIV incidence and risk behavior trends among injection drug users. He published more than 100 peer-reviewed articles in scientific journals.
“Doug was dedicated to his work and to advancing the field by assisting young researchers and peers to further the science of substance abuse research,” added Dr. Anglin. “His efforts have produced a better understanding of substance abuse and have resulted in improvements in the design and delivery of treatment services, especially for ethnic minority populations and those afflicted with substance abuse and HIV/AIDS.”
The Longshore Memorial Fund was established to help UCLA ISAP continue Dr. Longshore’s legacy of hard work, dedication, and compassion in helping those afflicted by substance abuse. Information about the work of UCLA ISAP can be found at www.uclaisap.org; a general summary follows:
UCLA ISAP Mission
UCLA ISAP conducts research, provides research training and clinical training, and arranges treatment for substance use disorders in coordination with the UCLA Department of Psychiatry and Biobehavioral Sciences and in affiliation with community-based treatment providers. ISAP efforts range from epidemiological and policy studies to clinical trials of innovative behavioral therapies and pharmacotherapies (visit http://www.uclaisap.org/html/synopsis.html for more details).
UCLA was established in 1999 to strengthen drug abuse research efforts and to improve treatment services. Heading into its second decade in a time of budgetary difficulties, ISAP is well positioned to extend that process. The group continues to advance the knowledge base on drug problems and to improve the delivery of treatment services through diverse efforts. Examples of these ongoing efforts include:
- Development of medication and behavioral treatments through ISAP’s role leading the Pacific Region Node of NIDA’s Clinical Trials Network (e.g., buprenorphine for cocaine dependence) and through NIDA-funded and industry-sponsored clinical trials of medications (e.g., methylphenidate for methamphetamine dependence, buprenorphine and Probuphine™ for opioid dependence) and behavioral treatments (Cognitive Behavioral Therapy and Contingency Management). ISAP also is investigating alternative/complementary approaches such as mindfulness/meditation, drumming, and aerobic exercise for methamphetamine dependence.
- Providing a resource for methodological expertise via the NIDA-funded Center for Advancing Longitudinal Drug Abuse Research.
- Involvement in international activities through arrangements with the United Nations Office on Drugs and Crime (“Treatnet”) to develop regional addiction training centers around the world, as well as clinical research and training efforts in China, Vietnam, Iraq, Thailand, and Egypt.
- Conducting research focused on special populations, including drug-abusing offenders via NIDA’s Pacific Coast Center for Criminal Justice Drug Abuse Treatment Studies and numerous studies on prison services and post-release services, women, adolescents, and gay, men-who-have-sex-with-men, and transgender populations.
- Hosting research training programs in addiction research methods via the NIDA T32 training grant for pre- and post-doctoral fellows, and numerous international visiting research fellows supported by the NIDA/CTN INVEST program.
- Disseminating knowledge about substance use disorders and research-based interventions and treatment skills throughout the nation via the Pacific Southwest Addiction Technology Transfer Center, technical assistance contracts for the State of California and Los Angeles County Department of Mental Health, as well as through other trainings delivered around the nation and the world.
- Strengthening technical assistance collaborations with government agencies via contracts with Los Angeles County Substance Abuse Prevention and Control and the California Department of Alcohol and Drug Programs.
ISAP will continue to advance the empirical understanding of substance use disorders, develop and evaluate new approaches for the treatment of addiction, and support efforts to reduce substance use and related problems.
For more information about the current work and future plans of UCLA ISAP, please contact ISAP Associate Director Christine Grella at email@example.com or 310-267-5451.